Synopsis
Fifty-three contributions provide up-to- date, clinically-oriented coverage of the latest techniques, devices, and adjunctive therapies related to percutaneous coronary revascularization, as well as critiques of emerging therapeutic approaches. In this edition, there is new or expanded coverage of drug-coated stents, inflammation and arterial injury, angiogenesis, percutaneous bypass surgery, device genomics, hypertrophic cardiomyopathy, stem cell therapy for ischemic heart disease, prophylactic aspirin use, detection of vulnerable plaque, the amplified impact of non-coronary interventions, improvements in adjunctive pharmacotherapy, and current material on congenital heart disease and restenosis. Illustrated with color and b&w images. Edited by Eric J. Topol of The Cleveland Clinic Foundation. Annotation c. Book News, Inc., Portland, OR
Eric D. Grassman
This is the third edition of a classic book by one of the world's leaders in interventional cardiology. The purpose is to present evidence-based data on the indications, technology, and expectations of modern interventional cardiology. It is intended for interventional cardiologists and interventional cardiology fellows. It covers basic science, techniques, clinical indications, medical-legal aspects, and financial issues. Overall, this is an excellent review. In such a rapidly changing field, a fourth edition will be needed in the near future.